カテゴリ： GlobalData, アメリカ, 企業調査

UnitedHealth Group Inc (UNH)-製薬・医療分野：企業M&A・提携分析

◆英語タイトル：UnitedHealth Group Inc (UNH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード：DATA8012238
◆発行会社（調査会社）：GlobalData
◆発行日：2017年12月14日
◆ページ数：88
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single UserUSD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
UnitedHealth Group Inc (UnitedHealth Group) is a diversified health care company. It offers health care services and products through two distinct platforms, namely UnitedHealthcare and Optum. Its UnitedHealthcare platform provides health care coverage and benefit services; and Optum platform provides information and technology-enabled health services. UnitedHealth Group offers health coverage, medicare plans, short-term health insurance and medicaid plans for individuals and families; health management and global health solutions for employers; health care network, value-based care; and clinician resources for physicians and health care professionals; and resources for brokers and consultants. The company offers its solutions and services to its members in the US and other countries. UnitedHealth Group is headquartered in Minnesota, the US.

UnitedHealth Group reported its total premiums earned as US$144,118 million in FY2016, an increase of 13.3% over US$127,163 million in FY2015.

UnitedHealth Group Inc (UNH) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
UnitedHealth Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
UnitedHealth Group Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
UnitedHealth Group Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
UnitedHealth Group Inc, Medical Devices Deals, 2011 to YTD 2017 9
UnitedHealth Group Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
UnitedHealth Group Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Audax Health Raises US$21 Million In Venture Financing 12
Audax Health Secures US$6 Million In Venture Financing 13
Partnerships 14
UnitedHealthcare Partners With American Gastroenterological Association To Improve Patient Care 14
Debt Offering 15
UnitedHealth Completes Public Offering Of Notes Due 2015 For US$625 Million 15
UnitedHealth Completes Public Offering Of Notes Due 2017 For US$625 Million 17
UnitedHealth Completes Public Offering Of Notes Due 2042 For US$625 Million 19
UnitedHealth Completes Public Offering Of Notes Due 2023 For US$625 Million 21
Family HealthCare Network Completes Private Placement Of Revenue Bonds For US$5 Million 23
UnitedHealth Group Completes Public Offering Of 3.375% Senior Unsecured Notes Due 2021 For US$500 Million 24
UnitedHealth Group Completes Public Offering Of 4.625% Senior Unsecured Notes Due 2041 For US$600 Million 25
UnitedHealth Group Completes Public Offering Of 1.875% Senior Unsecured Notes Due 2016 For US$400 Million 26
UnitedHealth Group Completes Public Offering Of Senior Unsecured Notes Due 2041 For US$350 Million 27
UnitedHealth Group Completes Public Offering Of Senior Unsecured Notes Due 2021 For US$400 Million 28
Asset Transactions 29
WellCare Health Completes Acquisition Of Medicaid Business Of UnitedHealth 29
Acquisition 31
Optum Acquires Alere Health for USD600 Million 31
UnitedHealth Acquires Catamaran for USD12.8 Billion 33
OptumRx Acquires Catamaran 35
Catamaran Acquires Healthcare Solutions for USD405 Million 37
Optum Acquires MedExpress Urgent Care 38
Optum Acquires Majority Stake In Audax Health 39
UnitedHealth Completes Acquisition Of Additional 24.68% Stake In Amil Participacoes For US$1.4 Billion 40
UnitedHealthcare Completes Acquisition Of XLHealth, Healthcare Services Company 42
inVentiv Health Completes Acquisition Of i3 From Ingenix 44
Catalyst Health Completes Acquisition Of Walgreens Health 46
UnitedHealth Group Inc – Key Competitors 48
UnitedHealth Group Inc – Key Employees 49
UnitedHealth Group Inc – Locations And Subsidiaries 51
Head Office 51
Other Locations & Subsidiaries 51
Recent Developments 53
Financial Announcements 53
Oct 17, 2017: UnitedHealth Group Third Quarter Highlights 53
Jul 18, 2017: UnitedHealth Group Second Quarter Highlights 55
Apr 18, 2017: UnitedHealth Group First Quarter Highlights 56
Jan 17, 2017: UnitedHealth Group Reports 2016 Results Highlighted by Continued Strong and Diversified Growth 57
Oct 18, 2016: UnitedHealth Group Reports Third Quarter Results 60
Jul 19, 2016: Unitedhealth Group Reports Second Quarter Results 62
Apr 19, 2016: UnitedHealth Group Reports First Quarter Results 64
Jan 19, 2016: UnitedHealth Group Reports 2015 Results Highlighted by Continued Strong and Diversified Growth 66
Corporate Communications 68
Aug 16, 2017: UnitedHealth Group Announces New Leadership Roles 68
Aug 07, 2017: UnitedHealth Group Names Two New Directors 69
Jan 17, 2017: UnitedHealth Group appoints Timothy P. Flynn to board of directors 70
Jun 09, 2016: UnitedHealth Group Continues to Evolve Leadership 71
Mar 17, 2016: UnitedHealthcare and Optum Support People Affected by Floods in Mississippi 72
Mar 17, 2016: UnitedHealthcare and Optum Support People Affected by Floods in Texas 73
Mar 11, 2016: UnitedHealthcare and Optum Support People Affected by Floods in Louisiana 74
Legal and Regulatory 75
Jul 13, 2017: Zuckerman Spaeder Files Class Action Complaint Against UnitedHealth Group For Violation Of Mental Health Parity Laws 75
Government and Public Interest 76
Jun 27, 2016: UnitedHealthcare Awards $75,000 in Grants to Nebraska Federally Qualified Health Centers to Improve Coordination of Physical and Behavioral Health Care 76
Other Significant Developments 78
Jul 20, 2016: USMD and UnitedHealthcare to Improve Patients’ Care in Dallas/Fort Worth 78
Jun 23, 2016: March of Dimes, UnitedHealth Group Launch Group Prenatal Care Program to Help Improve Health Outcomes for Mothers and Babies, and Reduce Health Care Costs 79
Feb 18, 2016: UnitedHealthcare and Chicanos Por La Causa Open myCommunity Connect Center in Maryvale to Broaden Access to Social Services for Low-Income Residents 81
Feb 17, 2016: UnitedHealthcare Community Plan Expands Service Area; Now Available in 43 New York Counties 83
Feb 15, 2016: Florida Accountable Care Services and UnitedHealthcare are Improving Patients’ Care in Central Florida 84
Jan 07, 2016: UnitedHealthcare’s “Solutions for Caregivers” Provides Comprehensive Resources to Help People Care for Aging or Disabled Family Members 86
Appendix 88
Methodology 88
About GlobalData 88
Contact Us 88
Disclaimer 88

List of Tables
UnitedHealth Group Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
UnitedHealth Group Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
UnitedHealth Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
UnitedHealth Group Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
UnitedHealth Group Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
UnitedHealth Group Inc, Medical Devices Deals, 2011 to YTD 2017 9
UnitedHealth Group Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Audax Health Raises US$21 Million In Venture Financing 12
Audax Health Secures US$6 Million In Venture Financing 13
UnitedHealthcare Partners With American Gastroenterological Association To Improve Patient Care 14
UnitedHealth Completes Public Offering Of Notes Due 2015 For US$625 Million 15
UnitedHealth Completes Public Offering Of Notes Due 2017 For US$625 Million 17
UnitedHealth Completes Public Offering Of Notes Due 2042 For US$625 Million 19
UnitedHealth Completes Public Offering Of Notes Due 2023 For US$625 Million 21
Family HealthCare Network Completes Private Placement Of Revenue Bonds For US$5 Million 23
UnitedHealth Group Completes Public Offering Of 3.375% Senior Unsecured Notes Due 2021 For US$500 Million 24
UnitedHealth Group Completes Public Offering Of 4.625% Senior Unsecured Notes Due 2041 For US$600 Million 25
UnitedHealth Group Completes Public Offering Of 1.875% Senior Unsecured Notes Due 2016 For US$400 Million 26
UnitedHealth Group Completes Public Offering Of Senior Unsecured Notes Due 2041 For US$350 Million 27
UnitedHealth Group Completes Public Offering Of Senior Unsecured Notes Due 2021 For US$400 Million 28
WellCare Health Completes Acquisition Of Medicaid Business Of UnitedHealth 29
Optum Acquires Alere Health for USD600 Million 31
UnitedHealth Acquires Catamaran for USD12.8 Billion 33
OptumRx Acquires Catamaran 35
Catamaran Acquires Healthcare Solutions for USD405 Million 37
Optum Acquires MedExpress Urgent Care 38
Optum Acquires Majority Stake In Audax Health 39
UnitedHealth Completes Acquisition Of Additional 24.68% Stake In Amil Participacoes For US$1.4 Billion 40
UnitedHealthcare Completes Acquisition Of XLHealth, Healthcare Services Company 42
inVentiv Health Completes Acquisition Of i3 From Ingenix 44
Catalyst Health Completes Acquisition Of Walgreens Health 46
UnitedHealth Group Inc, Key Competitors 48
UnitedHealth Group Inc, Key Employees 49
UnitedHealth Group Inc, Subsidiaries 51

★海外企業調査レポート[UnitedHealth Group Inc (UNH)-製薬・医療分野：企業M&A・提携分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Nova Eye Medical Ltd (EYE)：企業の財務・戦略的SWOT分析
    Nova Eye Medical Ltd (EYE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Antibe Therapeutics Inc (ATE)-製薬・医療分野：企業M&A・提携分析
    Summary Antibe Therapeutics Inc (Antibe) is a biotechnology company that designs and develops drug candidates for chronic pain and inflammation; and regenerative medicine. The company discovers and commercialize novel drugs, biologics and medical devices. It offers lead compound ATB-346, a naproxen …
  • Empresa Electricidad del Peru SA (ELECPBC1)：企業の財務・戦略的SWOT分析
    Empresa Electricidad del Peru SA (ELECPBC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • East Japan Railway Co：企業の戦略・SWOT・財務分析
    East Japan Railway Co - Strategy, SWOT and Corporate Finance Report Summary East Japan Railway Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Shire Plc (SHP)：企業の財務・戦略的SWOT分析
    Shire Plc (SHP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • JALUX Inc：企業の戦略・SWOT・財務情報
    JALUX Inc - Strategy, SWOT and Corporate Finance Report Summary JALUX Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Lidds AB (LIDDS)：企業の財務・戦略的SWOT分析
    Summary Lidds AB (Lidds) is a developer of pharmaceutical products for the treatment of cancer and other diseases. The company offers Liproca Depot, an injectable product used for the treatment of prostate cancer. Its Liproca is a bioresorbable, biocompatible and locally injectable modified release …
  • Porto Seguro SA：企業の戦略・SWOT・財務分析
    Porto Seguro SA - Strategy, SWOT and Corporate Finance Report Summary Porto Seguro SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Pine Cliff Energy Ltd (PNE)：企業の財務・戦略的SWOT分析
    Summary Pine Cliff Energy Ltd (Pine Cliff) is an oil and gas company that offers exploration, production, and development of natural gas, crude oil, and natural gas liquids. The company operates through its core areas such as Edson Assets, Central Assets, and Southern Assets. It acquired Hatton prop …
  • Scottish and Southern Energy plc：企業の戦略・SWOT・財務情報
    Scottish and Southern Energy plc - Strategy, SWOT and Corporate Finance Report Summary Scottish and Southern Energy plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Sequana SA (SEQ)：企業の財務・戦略的SWOT分析
    Sequana SA (SEQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • M3 Biotechnology Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary M3 Biotechnology Inc (M3 Biotech) is a clinical stage biotech company that focuses on regenerative medicine. The company is developing clinical programs for the treatment of Alzheimer, MS, Parkinson and Alzheimerdisease (oral) among others. It utilizes discovery platform and develops small m …
  • UbiVac LLC：製薬・医療：M&Aディール及び事業提携情報
    Summary UbiVac LLC (UbiVac) is a clinical stage immuno-oncology companythat offers immunotherapeutic products. The company offers research and development of therapeutic vaccines for the treatment of cancer and infectious diseases. Its pipeline product includes DPV-001, a DC-targeted complex vaccine …
  • Eastern Company SAE：企業の戦略・SWOT・財務分析
    Eastern Company SAE - Strategy, SWOT and Corporate Finance Report Summary Eastern Company SAE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • SK Holdings Co Ltd (034730)：企業の財務・戦略的SWOT分析
    SK Holdings Co Ltd (034730) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Venn Life Sciences Holdings Plc (VENN)：企業の財務・戦略的SWOT分析
    Summary Venn Life Sciences Holdings Plc (Venn Life Sciences), formerly Armscote Investment Company Plc is a contract research organization that offers drug development, clinical trial management and resourcing solutions. The organization offers drug development services such as clinical pharmacology …
  • Opsens Inc (OPS)：企業の財務・戦略的SWOT分析
    Summary Opsens Inc (Opsens), formerly DCB Capital Inc, is a provider of fiber optic sensing technology solutions. It focuses on fractional flow reverse guidewire in interventional cardiology. It offers OptoWire, an optical-based pressure guidewire, which enhances the clinical outcome of patients wit …
  • Cincinnati Bell Inc (CBB)：企業の財務・戦略的SWOT分析
    Cincinnati Bell Inc (CBB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Dance Biopharm Inc：医療機器：M&Aディール及び事業提携情報
    Summary Dance Biopharm Inc (Dance Biopharm), a subsidiary of Dance Biopharm Holdings Inc, formerly Dance Pharmaceuticals Inc, is a biotechnology company that develops inhaled insulin products to treat diabetes patients. The company provides product pipeline such as Dance-501, a pocket-sized inhaler …
  • AntriaBio Inc (ANTB)-製薬・医療分野：企業M&A・提携分析
    Summary AntriaBio Inc (AntriaBio), formerly AntriaBio Delaware Inc is a biopharmaceutical company that develops drug therapies for the treatment of diabetes and metabolic diseases. The company’s lead product candidate include AB10, human recombinant insulin for use in type 1 and type 2 diabetes for …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆